Lab
Twin Brothers INC
Twin Brothers INC was paid $736K by Medicaid between Jun 2019 and Dec 2024, across 33 billing codes. Its largest line is 87635, Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe — 21% of everything it billed.
33Billing provider infoTWIN BROTHERS INC
CATANO, PR 00962
CATANO, PR 00962
33aNPI1447634530assigned 07/17/2015
33bProvider typeClinical Medical Laboratory
28Total paid$736K
24GClaims38,362
24DCodes billed33
24AFirst – last monthJun 2019 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#173 of 777
Median peer was paid$278K
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 327 | $3K | |
| 2020 | 3,888 | $68K | |
| 2021 | 9,449 | $220K | |
| 2022 | 10,279 | $243K | |
| 2023 | 8,225 | $125K | |
| 2024incomplete | 6,194 | $77K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 21% | 3,077 | 2,914 | $155K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 20% | 5,963 | 5,524 | $144K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 18% | 3,192 | 3,031 | $136K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.8% | 4,486 | 4,221 | $35K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.7% | 2,087 | 2,026 | $35K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.6% | 2,605 | 1,388 | $34K |
| 86738 | 3.8% | 1,896 | 1,830 | $28K | |
| 80061 | Lipid panel | 3.6% | 1,941 | 1,887 | $26K |
| 80053 | Comprehensive metabolic panel | 3.4% | 2,346 | 2,232 | $25K |
| 86328 | 2.8% | 1,115 | 1,068 | $20K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.4% | 373 | 341 | $18K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.3% | 595 | 573 | $17K |
21 more codes
| 36415 | Collection of venous blood by venipuncture | 1.4% | 1,518 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.3% | 950 | $9K |
| 81000 | 1.1% | 2,536 | $8K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 162 | $7K |
| 86701 | <1% | 690 | $6K | |
| 80074 | <1% | 81 | $4K | |
| 87590 | <1% | 141 | $3K | |
| 84439 | <1% | 323 | $3K | |
| 87088 | <1% | 280 | $2K | |
| 82274 | <1% | 140 | $2K | |
| 86592 | <1% | 372 | $2K | |
| 82043 | <1% | 234 | $1K | |
| 82570 | <1% | 263 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 158 | $1K |
| 84436 | <1% | 110 | $730.44 | |
| 84479 | <1% | 119 | $527.10 | |
| 82607 | <1% | 13 | $209.49 | |
| 86695 | <1% | 14 | $186.94 | |
| 85730 | <1% | 12 | $78.48 | |
| 85610 | <1% | 12 | $51.48 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 558 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORENO RODRIGUEZ, JOSE (PRESIDENT)